NCT05441709 Furthering Equity Through Infant Feeding EDucation and Support
| NCT ID | NCT05441709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Endeavor Health |
| Condition | Breastfeeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 990 participants |
| Start Date | 2022-11-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 990 participants in total. It began in 2022-11-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to identify whether adding clinically integrated breastfeeding peer counseling (ci-BPC) to standard lactation care is associated with a reduction in disparities in breastfeeding intensity and duration for Black and Hispanic/Latine families.
Eligibility Criteria
Inclusion Criteria: * 12 and 24 weeks gestation * English or Spanish speaking * Planning to parent their infant * Planning to deliver at SH, HPH or UCM * No prior exposure to ci-BPC Exclusion Criteria: * considering pregnancy termination or adoption * Prior exposure to ci-BPC
Contact & Investigator
Ann Borders, MD, MS
PRINCIPAL INVESTIGATOR
Endeavor Health (NorthShore University HealthSystem)
Frequently Asked Questions
Who can join the NCT05441709 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Breastfeeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05441709 currently recruiting?
Yes, NCT05441709 is actively recruiting participants. Contact the research team at lkeenan-devlin@northshore.org for enrollment information.
Where is the NCT05441709 trial being conducted?
This trial is being conducted at Chicago, United States, Chicago, United States, Evanston, United States, Highland Park, United States.
Who is sponsoring the NCT05441709 clinical trial?
NCT05441709 is sponsored by Endeavor Health. The principal investigator is Ann Borders, MD, MS at Endeavor Health (NorthShore University HealthSystem). The trial plans to enroll 990 participants.